Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05338931 |
|---|---|
| Brief Title: | Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma |
| First Submitted : | April 1, 2022 |
| First Submitted that Met QC Criteria : | April 14, 2022 |
| First Posted : | April 21, 2022 |
| Last Update Submitted that Met QC Criteria : | May 24, 2022 |
| Last Update Posted : | May 26, 2022 |